Friday, November 10, 2006 6:45 AM to 8:45 AM


A CME Breakfast Symposium

Friday, November 10, 2006
6:45 AM to 8:45 AM
The Venetian Resort Hotel Casino
3355 Las Vegas Blvd S
Las Vegas, Nevada


Target Audience

This educational activity is intended for comprehensive ophthalmologists.

Program Chairman and Moderator

Terrence P. O'Brien, MDProfessor of OphthalmologyCharlotte Breyer Rodgers Distinguished Chair in Ophthalmology
Director of the Refractive Surgery Service

Bascom Palmer Eye Institute of the Palm Beaches
Palm Beach, Florida


Deepinder K. Dhaliwal, MDAssociate Professor of Ophthalmology
University of Pittsburgh School of Medicine
Director, Cornea & External Disease Service
Director, Refractive Surgery Service
UPMC Eye Center
Medical Director
UPMC Laser/Aesthetic Center
Pittsburgh, Pennsylvania

Terry Kim, MDAssociate Professor of Ophthalmology
Duke University School of Medicine
Associate Director
Cornea and Refractive Surgery
Duke University Eye Center
Durham, North Carolina

Francis S. Mah, MDAssistant Professor of Ophthalmology, Cornea, External Disease, and Refractive Surgery ServiceCo-Medical Director, The Charles T. Campbell Eye Microbiology Lab
Department of Ophthalmology
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Michael B. Raizman, MDAssociate Professor of Ophthalmology
Tufts University School of Medicine
Ophthalmic Consultants of Boston
Cornea and Anterior Segment Service
New England Eye Center
Boston, Massachusetts

Target Audience
This educational activity is intended for comprehensive ophthalmologists.

Statement of Need and Activity Description
Ocular allergies are increasing in prevalence and while the cause is not established the effects of pollution and lifestyles that limit childhood exposure to allergens are thought to contribute greatly. Patients may be unaware that their symptoms are due to allergy, or are aware but self-medicate, and proper treatment is thus not sought or delayed. Early detection and treatment are necessary to prevent loss in quality of life and even ocular damage. Management of ocular allergic reactions seeks to reduce symptoms, ideally with avoidance of the allergen. This may not always be possible. New treatments and management strategies for ocular allergies have been developed recently. This symposium will update ophthalmologists on the latest developments in ocular allergies to assist them with management of this growing problem.

Learning Objectives
Upon completion of this activity, participants should be able to:

Agenda6:45 AM - 7:15 AM - Registration

7:15 AM - 7:25 AM - Welcome and Introduction
The Scope of the Problem
Terrence P. O'Brien, MD
7:25 AM - 7:33 AM - Update on Ocular Allergies in Children
Terry Kim, MD
7:33 AM - 7:42 AM - Update on Ocular Allergies in Adults
Michael B. Raizman, MD
7:42 AM - 7:50 AM - The Importance of Refractive Surgery in Ocular Allergy
Deepinder K. Dhaliwal, MD
7:50 AM - 8:00 AM - New Treatments in Ocular Allergy
Francis S. Mah, MD
8:00 AM - 8:35 AM - Interactive Session and Case Discussion
8:35 AM - 8:45 AM - Q&A Session


Accreditation Statement
This continuing medical education activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The New York Eye and Ear Infirmary and cme2, an independent subsidiary of Advanstar Communications Inc, publisher of Ophthalmology Times. The New York Eye and Ear Infirmary is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The New York Eye and Ear Infirmary designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy Statement
The New York Eye and Ear Infirmary requires that each participant/teacher in a CME-accredited educational activity disclose the existence of any financial interest and/or other relationship(s) (eg, paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation. Speakers are also asked to make a disclosure that a product is still investigational when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity. The disclosed information in no way presumes to assess the participant's qualifications or suitability. The intention is to provide full disclosure of any potential conflict of interest, real or perceived, which is related to a specific event. Full disclosure of faculty and commercial relationships, if any, will be made at the program.

Provider Disclosure
The New York Eye and Ear Infirmary received a financial benefit from Alcon Laboratories, Inc to administer this educational activity.

or call 888-248-0036
or 218-740-7130

Related Videos
© 2023 MJH Life Sciences

All rights reserved.